Richard McFarland

Richard McFarland

Company: Standards Coordinating Body

Job title: President


Ph.D., MD is the Chief Regulatory Officer Chief Regulatory Officer of ARMI/BioFabUSA. Prior to ARMI he was Associate Director of Policy for FDA/CBER’s Office of Tissues and Advanced Therapies and its predecessor office, the Office of Cellular, Tissue and Gene Therapies. In this position, he was heavily involved in policy development for tissue engineering, regenerative medicine, and alternatives to animal use in regulatory decision making. Dr. McFarland received his B.S., Ph.D., and M.D. from the University of North Carolina at Chapel Hill, and completed his anatomic/clinical pathology residency and immunopathology fellowship training at UT Southwestern in Dallas.


Panel Discussion: Can Cell Therapy Supply Chains be Standardized, and Developing Best Practice Guidelines for Efficiency at Scale and Better Patient Care 11:45 am

Download The Full Event Guide Read more

day: Day Two

Standardizing Processes at the Front-End of the Supply Chain to Optimize Clinical Interfaces and Starting Material Quality 3:45 pm

Download The Full Event Guide Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.